SlideShare a Scribd company logo
1 of 22
Download to read offline
ABSORPTION OF DRUGS FROM
NON PER OS EXTRA VASCULAR
ROUTES
1
Contents1,2
 Introduction
 Definition
 Other than oral routes
 Advantages
 Summary
 Conclusion
 References
2
Introduction1
 NON PER OS Means other than oral routes which by
passes the GIT and reaches to systemic circulation.
 One of the major advantages of administering drugs
by non-invasive transmucosal (& transdermal) routes
such as nasal, buccal, rectal, etc. is that greater
systemic availability is attainable
3
1
4
5
NON PER OS ROUTES1,2
 BUCCAL/SUBLINGUAL
 RECTAL
 TOPICAL
 INTRAMASCULAR
 SUBCUTANIOUS
 PULMONARY
 INTRANASAL
 INTRAOCCULAR
 VAGINAL
6
1. BUCCAL/SUBLINGUAL1,3
 Buccal Route : The medicament is placed between cheek and the
gum.(Glyceryl trinitrate)
 Sublingual Route : The drug is placed under the tongue and allowed
to dissolve.(Ergotamine)
 Advantages :-
a) Rapid absorption
b) No first-pass hepatic metabolism
c) No degradation of drugs
 Factors:-
a) Lipophilicity of drugs
b) Salivary secretion
c) PH of the saliva
d) Binding to oral mucosa
e) Thickness of oral epithelium
BUCCAL/SUBLINGUAL SITE 2
7
8
2. RECTAL1,2
 The rectal route of administration is still an important
route for Children & Old Patients.
 The drug may be administered as solutions(microenemas)
or suppositories.
 Advantage :-
a) Absorption is more rapid
b) Bypasses presystemic hepatic metabolism
 Factors:-
1. Presence of faecal matter
2. pH of rectal fluid ( Around 8)
3. Drug Irritability
4. Surface area
9
3. TOPICAL1,2
 Skin is largest organ of the body. Skin is commonly employed as a
site of drug administration for local as well as systemic effect.
 Liquid dosage forms such as Liniments,Lotions,Sprays.
 Semisolids like Ointments,Creams,Pastes,Gels ,etc are
conventional drug forms for topical drug delivery
 Advantages:-
a) Protect drug from GI & from first pass metabolism
b) Increased patient compliance by reduced dosing frequency
c) Easy to terminate drug therapy by removing transdermal patch
 Factors:-
a) Skin condition
b) Composition of topical vehicle
c) Application procedure
d) External/environmental factors
TOPICAL SITE1
10
11
4. INJECTIONS1,2
 Intravenous(IV) Injection.
 Drug is directly goes into blood stream
 Intramuscular(IM) Injection.
 Absorption of drugs from I.M. sites is relatively rapid but much slower
than I.V. injection.
 Subcutaneous(SC) Injection.
 Absorption is slower than I.M. site due to poor perfusion
 Intraperitoneal(IP) Injection.
 I.P.route is rarely employed in human beings but most widely used in
laboratory animals
INJECTIONS CONTINUED…..
12
 Factors :-
a) Vascularity of injection site
b) Lipid solubility & Ionisation of drug
c) Molecular size of the drug
d) Volume of injection/Drug concentration
e) PH, composition & viscosity of injection vehicle
13
6. PULMONARY1,2
 All drugs intended for systemic effect can be administered
by inhalation since the large surface area of the alveoli .
 Advantages:-
a) Rapid absorption just like exchange of gases between the
blood and the inspired air
b) Lipid-soluble drugs are rapidly absorbed by passive
diffusion
c) Polar drugs absorbed by pore transport
14
PULMONARY CONTINUED….
 Factors:-
a) Particle size of drug
b) Properties of propeller such as vapour
pressure,toxicity,solvent action
c) Effect of drugs and additives on mucous
viscosity,mucocilliary clearence
15
7. INTRANASAL1
 The nasal route is becoming increasingly popular for systemic delivery
especially of some peptide and protein drugs
 Advantages:-
a) Rapid absorption due to rich vasculature and high permeability
b) Drugs from this route reaches the systemic circulation may cross BBB
 FACTORS:-
a) Required high lipophilic drugs
b) Smaller molecular weight is required
c) pH of nasal secretion
d) Pathological condition
16
8. INTRAOCCULAR2
 Topical application of drugs to the eyes is mainly meant for
local effects such as mydriasis, miosis, anaesthesia or
treatment of infections,gloucoma,etc.
 Advantages:-
a) Lipophilic as well as Hydrophilic drugs are absorbed
b) pH of lachrymal fluid influence absorption of weak
electrolytes
 Factors:-
a) Rate of blinking shows loss of drug
b) Viscosity of drug also affect on absorption
17
9. VAGINAL1,2
 Drugs meant for intravaginal application are
ganerally intended to act locally in the treatment of
bacterial or fungal infection or prevent conception
 Advantages:-
a) Easy administration
b) Controlled delivery & termination of drug action
when desired, with this route
SUMMARY OF MECHANISM AND DRUGS ABSORBED
FROM VARIOUS NON INVASIVE ROUTES1:-
18
ROUTES ABSORPTION
MECHANISM
DRUG DELIVERED
1.Buccal/Sublingual Passive
diffusion,carriar
mediated transport
Nitrites,antianginal,mo
rphine,etc.
2.Rectal Passive diffusion Aspirin,Paracetamol,ba
rbiturates,etc.
3.Transdermal Passive diffusion Nitroglycerine,lidocaine
,etc.
4.Intramuscular Passive diffusion,
endocytosis,pore
transport
Phenytoin, digitoxine
5.Subcutaneous Passive diffusion Insuline, heparin,etc.
6.Inhalation Passive diffusion,Pore
transport
Salbutamol, cromolyn
19
ROUTES ABSORPTION
MECHANISM
DRUG DELIVERED
7.Intranasal Passive diffusion,
Pore transport
Phenylpropanolamine,
antihistaminics
8.Intraocular Passive diffusion Atropine,pilocarpine
9.Vaginal Passive diffusion Steroidal drugs &
contraceptives
20
CONCLUSION1,2
 Absorption of drug is rapid
 Directly reaches the systemic circulation
 Avoid the GI degradation and/or hepatic
metabolism
 Easy to administered
 Shows the more bioavailability than oral
route
21
REFERANCES
1. Brahmankar D. M., Jaiswal S.B.,
Biopharmaceutics & Pharmacokinetics A
Treatise, Second Edition 2009 Published by
Jain M.K. for Vallabh Prakashan, Delhi.81-92.
2. Kulkarni J.S., Pawar A.P., Shedbalkar V.P.,
Biopharmaceutics & Pharmacokinetics First
edition 2006, CBS Publication,New Delhi.47-
59.
3. www.vodlo.com
THANK YOU
22

More Related Content

What's hot

Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsSnehal Patel
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of DissolutionPRASHANT DEORE
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionchiranjibi68
 
Mechanism of drug absorption in git
Mechanism of drug absorption in gitMechanism of drug absorption in git
Mechanism of drug absorption in gitAnjita Khadka
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugsSuvarta Maru
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsAmeer Ahmed
 
Preformulation Studies
Preformulation StudiesPreformulation Studies
Preformulation StudiesTeny Thomas
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugswonderingsoul114
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studiesSonam Gandhi
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification systemAshwani Kumar Singh
 
Factors affecting protein drug binding and rotein drug binding
Factors affecting protein drug binding and rotein drug bindingFactors affecting protein drug binding and rotein drug binding
Factors affecting protein drug binding and rotein drug bindingAshwani Kumar Singh
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceuticsSuvarta Maru
 

What's hot (20)

Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
ELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICSELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICS
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
Factors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kineticsFactors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kinetics
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Mechanism of drug absorption in git
Mechanism of drug absorption in gitMechanism of drug absorption in git
Mechanism of drug absorption in git
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugs
 
Biopharmaceutics complete notes
Biopharmaceutics complete notes Biopharmaceutics complete notes
Biopharmaceutics complete notes
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing Models
 
Preformulation Studies
Preformulation StudiesPreformulation Studies
Preformulation Studies
 
Phytosome
PhytosomePhytosome
Phytosome
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification system
 
Factors affecting protein drug binding and rotein drug binding
Factors affecting protein drug binding and rotein drug bindingFactors affecting protein drug binding and rotein drug binding
Factors affecting protein drug binding and rotein drug binding
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
 

Similar to Absorption of drugs from non per os extravascular administration

1.3 Non per oral ABSORPTION OF DRUGS.pptx
1.3 Non per oral ABSORPTION OF DRUGS.pptx1.3 Non per oral ABSORPTION OF DRUGS.pptx
1.3 Non per oral ABSORPTION OF DRUGS.pptxRani Dhole
 
Pharmacokineticsppt 130126012953-phpapp02
Pharmacokineticsppt 130126012953-phpapp02Pharmacokineticsppt 130126012953-phpapp02
Pharmacokineticsppt 130126012953-phpapp02Linda Amos
 
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjj
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjjpharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjj
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjjsanyAhmed3
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics Moha Haji
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptxrupeshdalavi
 
routesofdrugadministration ppt.pptx
routesofdrugadministration ppt.pptxroutesofdrugadministration ppt.pptx
routesofdrugadministration ppt.pptxMamtanaagar1
 
Ophthalmic drug delivery system :Challenges and Approaches.
Ophthalmic drug delivery system :Challenges and Approaches.Ophthalmic drug delivery system :Challenges and Approaches.
Ophthalmic drug delivery system :Challenges and Approaches.Ashish Kumar Mishra
 
General pharma
General pharmaGeneral pharma
General pharmaHiba Hamid
 
Approaches for injectable controlled release formulations
Approaches for injectable controlled release formulationsApproaches for injectable controlled release formulations
Approaches for injectable controlled release formulationschiranjibi68
 
Route of administration
Route of administrationRoute of administration
Route of administrationNaman Gupta
 
Routes of-drug-Administration
Routes of-drug-Administration Routes of-drug-Administration
Routes of-drug-Administration AJAYSARANGI2
 
3 drug absorption from the git
3 drug absorption from the git3 drug absorption from the git
3 drug absorption from the gitbernard kathewera
 
Disquisition on Routes of Drug Administration
Disquisition on Routes of Drug  AdministrationDisquisition on Routes of Drug  Administration
Disquisition on Routes of Drug AdministrationSMS MEDICAL COLLEGE
 
Factors affecting oral absorption by- Deepak kumar
Factors affecting oral absorption by- Deepak kumarFactors affecting oral absorption by- Deepak kumar
Factors affecting oral absorption by- Deepak kumarDeepak Kumar
 

Similar to Absorption of drugs from non per os extravascular administration (20)

1.3 Non per oral ABSORPTION OF DRUGS.pptx
1.3 Non per oral ABSORPTION OF DRUGS.pptx1.3 Non per oral ABSORPTION OF DRUGS.pptx
1.3 Non per oral ABSORPTION OF DRUGS.pptx
 
Pharmacokineticsppt 130126012953-phpapp02
Pharmacokineticsppt 130126012953-phpapp02Pharmacokineticsppt 130126012953-phpapp02
Pharmacokineticsppt 130126012953-phpapp02
 
Route of administation
Route of administationRoute of administation
Route of administation
 
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjj
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjjpharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjj
pharmacokineticsppt-4.pdfghjjjjkkkkkkkkkkjjj
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
Lecture 2. pharmakokinetic pptx
Lecture 2. pharmakokinetic pptxLecture 2. pharmakokinetic pptx
Lecture 2. pharmakokinetic pptx
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
routesofdrugadministration ppt.pptx
routesofdrugadministration ppt.pptxroutesofdrugadministration ppt.pptx
routesofdrugadministration ppt.pptx
 
Ophthalmic drug delivery system :Challenges and Approaches.
Ophthalmic drug delivery system :Challenges and Approaches.Ophthalmic drug delivery system :Challenges and Approaches.
Ophthalmic drug delivery system :Challenges and Approaches.
 
Ocular pharmacokinetics
Ocular pharmacokineticsOcular pharmacokinetics
Ocular pharmacokinetics
 
General pharma
General pharmaGeneral pharma
General pharma
 
Approaches for injectable controlled release formulations
Approaches for injectable controlled release formulationsApproaches for injectable controlled release formulations
Approaches for injectable controlled release formulations
 
Route of administration
Route of administrationRoute of administration
Route of administration
 
Routes of-drug-Administration
Routes of-drug-Administration Routes of-drug-Administration
Routes of-drug-Administration
 
Pharmacokinetics2
Pharmacokinetics2Pharmacokinetics2
Pharmacokinetics2
 
3 drug absorption from the git
3 drug absorption from the git3 drug absorption from the git
3 drug absorption from the git
 
Disquisition on Routes of Drug Administration
Disquisition on Routes of Drug  AdministrationDisquisition on Routes of Drug  Administration
Disquisition on Routes of Drug Administration
 
Factors affecting oral absorption by- Deepak kumar
Factors affecting oral absorption by- Deepak kumarFactors affecting oral absorption by- Deepak kumar
Factors affecting oral absorption by- Deepak kumar
 
Modes of Drug administration
Modes of Drug administrationModes of Drug administration
Modes of Drug administration
 

More from Suvarta Maru

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus Suvarta Maru
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )Suvarta Maru
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discoverySuvarta Maru
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugsSuvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drugSuvarta Maru
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trialsSuvarta Maru
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatmentSuvarta Maru
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDYSuvarta Maru
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDYSuvarta Maru
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)Suvarta Maru
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)Suvarta Maru
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 

More from Suvarta Maru (20)

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
 
US FDA
US FDA US FDA
US FDA
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Stroke study
Stroke studyStroke study
Stroke study
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugs
 
Schedule m
Schedule  m Schedule  m
Schedule m
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 

Recently uploaded

Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 

Recently uploaded (20)

Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 

Absorption of drugs from non per os extravascular administration

  • 1. ABSORPTION OF DRUGS FROM NON PER OS EXTRA VASCULAR ROUTES 1
  • 2. Contents1,2  Introduction  Definition  Other than oral routes  Advantages  Summary  Conclusion  References 2
  • 3. Introduction1  NON PER OS Means other than oral routes which by passes the GIT and reaches to systemic circulation.  One of the major advantages of administering drugs by non-invasive transmucosal (& transdermal) routes such as nasal, buccal, rectal, etc. is that greater systemic availability is attainable 3
  • 4. 1 4
  • 5. 5 NON PER OS ROUTES1,2  BUCCAL/SUBLINGUAL  RECTAL  TOPICAL  INTRAMASCULAR  SUBCUTANIOUS  PULMONARY  INTRANASAL  INTRAOCCULAR  VAGINAL
  • 6. 6 1. BUCCAL/SUBLINGUAL1,3  Buccal Route : The medicament is placed between cheek and the gum.(Glyceryl trinitrate)  Sublingual Route : The drug is placed under the tongue and allowed to dissolve.(Ergotamine)  Advantages :- a) Rapid absorption b) No first-pass hepatic metabolism c) No degradation of drugs  Factors:- a) Lipophilicity of drugs b) Salivary secretion c) PH of the saliva d) Binding to oral mucosa e) Thickness of oral epithelium
  • 8. 8 2. RECTAL1,2  The rectal route of administration is still an important route for Children & Old Patients.  The drug may be administered as solutions(microenemas) or suppositories.  Advantage :- a) Absorption is more rapid b) Bypasses presystemic hepatic metabolism  Factors:- 1. Presence of faecal matter 2. pH of rectal fluid ( Around 8) 3. Drug Irritability 4. Surface area
  • 9. 9 3. TOPICAL1,2  Skin is largest organ of the body. Skin is commonly employed as a site of drug administration for local as well as systemic effect.  Liquid dosage forms such as Liniments,Lotions,Sprays.  Semisolids like Ointments,Creams,Pastes,Gels ,etc are conventional drug forms for topical drug delivery  Advantages:- a) Protect drug from GI & from first pass metabolism b) Increased patient compliance by reduced dosing frequency c) Easy to terminate drug therapy by removing transdermal patch  Factors:- a) Skin condition b) Composition of topical vehicle c) Application procedure d) External/environmental factors
  • 11. 11 4. INJECTIONS1,2  Intravenous(IV) Injection.  Drug is directly goes into blood stream  Intramuscular(IM) Injection.  Absorption of drugs from I.M. sites is relatively rapid but much slower than I.V. injection.  Subcutaneous(SC) Injection.  Absorption is slower than I.M. site due to poor perfusion  Intraperitoneal(IP) Injection.  I.P.route is rarely employed in human beings but most widely used in laboratory animals
  • 12. INJECTIONS CONTINUED….. 12  Factors :- a) Vascularity of injection site b) Lipid solubility & Ionisation of drug c) Molecular size of the drug d) Volume of injection/Drug concentration e) PH, composition & viscosity of injection vehicle
  • 13. 13 6. PULMONARY1,2  All drugs intended for systemic effect can be administered by inhalation since the large surface area of the alveoli .  Advantages:- a) Rapid absorption just like exchange of gases between the blood and the inspired air b) Lipid-soluble drugs are rapidly absorbed by passive diffusion c) Polar drugs absorbed by pore transport
  • 14. 14 PULMONARY CONTINUED….  Factors:- a) Particle size of drug b) Properties of propeller such as vapour pressure,toxicity,solvent action c) Effect of drugs and additives on mucous viscosity,mucocilliary clearence
  • 15. 15 7. INTRANASAL1  The nasal route is becoming increasingly popular for systemic delivery especially of some peptide and protein drugs  Advantages:- a) Rapid absorption due to rich vasculature and high permeability b) Drugs from this route reaches the systemic circulation may cross BBB  FACTORS:- a) Required high lipophilic drugs b) Smaller molecular weight is required c) pH of nasal secretion d) Pathological condition
  • 16. 16 8. INTRAOCCULAR2  Topical application of drugs to the eyes is mainly meant for local effects such as mydriasis, miosis, anaesthesia or treatment of infections,gloucoma,etc.  Advantages:- a) Lipophilic as well as Hydrophilic drugs are absorbed b) pH of lachrymal fluid influence absorption of weak electrolytes  Factors:- a) Rate of blinking shows loss of drug b) Viscosity of drug also affect on absorption
  • 17. 17 9. VAGINAL1,2  Drugs meant for intravaginal application are ganerally intended to act locally in the treatment of bacterial or fungal infection or prevent conception  Advantages:- a) Easy administration b) Controlled delivery & termination of drug action when desired, with this route
  • 18. SUMMARY OF MECHANISM AND DRUGS ABSORBED FROM VARIOUS NON INVASIVE ROUTES1:- 18 ROUTES ABSORPTION MECHANISM DRUG DELIVERED 1.Buccal/Sublingual Passive diffusion,carriar mediated transport Nitrites,antianginal,mo rphine,etc. 2.Rectal Passive diffusion Aspirin,Paracetamol,ba rbiturates,etc. 3.Transdermal Passive diffusion Nitroglycerine,lidocaine ,etc. 4.Intramuscular Passive diffusion, endocytosis,pore transport Phenytoin, digitoxine 5.Subcutaneous Passive diffusion Insuline, heparin,etc. 6.Inhalation Passive diffusion,Pore transport Salbutamol, cromolyn
  • 19. 19 ROUTES ABSORPTION MECHANISM DRUG DELIVERED 7.Intranasal Passive diffusion, Pore transport Phenylpropanolamine, antihistaminics 8.Intraocular Passive diffusion Atropine,pilocarpine 9.Vaginal Passive diffusion Steroidal drugs & contraceptives
  • 20. 20 CONCLUSION1,2  Absorption of drug is rapid  Directly reaches the systemic circulation  Avoid the GI degradation and/or hepatic metabolism  Easy to administered  Shows the more bioavailability than oral route
  • 21. 21 REFERANCES 1. Brahmankar D. M., Jaiswal S.B., Biopharmaceutics & Pharmacokinetics A Treatise, Second Edition 2009 Published by Jain M.K. for Vallabh Prakashan, Delhi.81-92. 2. Kulkarni J.S., Pawar A.P., Shedbalkar V.P., Biopharmaceutics & Pharmacokinetics First edition 2006, CBS Publication,New Delhi.47- 59. 3. www.vodlo.com